Skip to main content
Log in

Control of doxorubicin release from magnetic Poly(dl-lactide-co-glycolide) nanoparticles by application of a non-permanent magnetic field

  • Research Paper
  • Published:
Journal of Nanoparticle Research Aims and scope Submit manuscript

Abstract

This work studied the effect of the application time of a non-permanent magnetic field on the rate of drug release from iron oxide polymeric nanoparticles. Magnetically responsive doxorubicin loaded poly(d-lactide-co-glycolide) (PLGA) nanoparticles were synthetized by the o/w solvent extraction/evaporation method and characterized. The produced particles show spherical shapes exhibiting a size between 200 and 400 nm, a drug loading of 3.6 % (w/w) and an iron concentration of 20.7 % (w/w). Cell cytotoxicity tests showed that unloaded magnetic PLGA nanoparticles were nontoxic. Concerning the therapeutic activity, doxorubicin-loaded magnetic particles cause a remarkable enhancement of the cell inhibition rates compared to their non-magnetic counterparts (40 against 7 % of dead cells). In vitro drug release studies performed under a non-permanent magnetic field show that the application time and the on/off cycle duration have a great influence with respect to the final amount and to the rate of drug release. The final amount and the rate of doxorubicin released increase with the time of field application reaching higher values for a higher number of pulses with a lower duration. Doxorubicin release mechanism has shown to be governed by Fickian diffusion in the absence of a magnetic field while in the presence of a magnetic field some controlled relaxation polymer chains might also be present. The results show that the drug release rate from magnetic PLGA nanoparticles can be modulated through the application time and the on/off cycles duration of a non-permanent magnetic field.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Scheme 1
Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  • Abdalla MO, Karna P, Sajja HK, Mao H, Yates C, Turner T, Aneja R (2011) Enhanced noscapine delivery using uPAR-targeted optical-MR imaging trackable nanoparticles for prostate cancer therapy. J Control Release 149:314–322

    Article  Google Scholar 

  • Alexiou C, Arnold W, Klein RJ, Parak FG, Hulin P, Bergemann C, Erhardt W, Wagenpfeil S, Lubbe AS (2000) Locoregional cancer treatment with magnetic drug targeting. Cancer Res 60:6641–6648

    Google Scholar 

  • Alexiou C, Schmid RJ, Bergemann C, Henke J, Erhardt W, Huenges E, Parak FJ (2003) Magnetic drug targeting biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment. J Drug Target 11:139–149

    Article  Google Scholar 

  • Andhariya N, Chudasama B, Mehta RV, Upadhyay RV (2011) Biodegradable thermoresponsive polymeric magnetic nanoparticles: a new drug delivery platform for doxorubicin. J Nanopart Res 13:1677–1688

    Article  Google Scholar 

  • Artemov D (2003) Molecular magnetic resonance imaging with targeted contrast agents. J Cell Biochem 90:518–524

    Article  Google Scholar 

  • Bicho A, Peça IN, Roque ACA, Cardoso MM (2010) Anti-CD8 conjugated nanoparticles to target mammalian cells expressing CD8. Int J Pharm 399:80–86

    Article  Google Scholar 

  • Cardoso MM, Peça IN, Roque ACA (2012) Antibody-conjugated nanoparticles for therapeutic applications. Curr Med Chem 19:3103–3127

    Article  Google Scholar 

  • da Silva EP, Sitta DLA, Fragal VH, Cellet TSP, Mauricio MR, Garcia FP, Nakamura CV, Guilherme MR, Rubira AF, Kunita MH (2014) Covalent TiO2/pectin microspheres with Fe3O4 nanoparticles for magnetic field-modulated drug delivery. Int J Biol Macromol 67:43–52

    Article  Google Scholar 

  • Demarchi CA, Debrassi A, Buzzi FC, Corrêa R, Filho VC, Rodrigues CA, Nedelko N, Demchenko P, Slawska-Waniewska A, Dłuzewski P, Greneche JM (2014) A magnetic nanogel based on O-carboxymethylchitosan for antitumor drug delivery: synthesis, characterization and in vitro drug release. Soft Matter 10:3441

    Article  Google Scholar 

  • Ditsch A, Lindenmann S, Laibinis PE, Wang DIC, Hatton TA (2005) High-gradient magnetic separation of magnetic nanoclusters. Ind Eng Chem Res 44:6824–6836

    Article  Google Scholar 

  • Fang C, Kievit FM, Veiseh O, Stephen ZR, Wang T, Lee D, Ellenbogen RG, Zhang M (2012) Fabrication of magnetic nanoparticles with controllable drug loading and release through a simple assembly approach. J Control Release 162:233–241

    Article  Google Scholar 

  • Gonzales M, Krishnan KM (2005) Synthesis of magnetoliposomes with monodisperse iron oxide nanocrystal cores for hyperthermia. J Magn Magn Mater 293:265–270

    Article  Google Scholar 

  • Guilherme MR, Oliveira RS, Mauricio MR, Cellet TSP, Pereira GM, Kunita MH, Muniz EC, Rubira AF (2012) Albumin release from a brain-resembling superabsorbent magnetic hydrogel based on starch. Soft Matter 8:6629–6637

    Article  Google Scholar 

  • Ito A, Tanaka K, Kondo K, Shinkai M, Honda H, Matsumoto K, Saida T, Kobayashi T (2003) Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma. Cancer Sci 94:308–313

    Article  Google Scholar 

  • Jung CW (1995) Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imaging 13:661–674

    Article  Google Scholar 

  • Kocbek P, Kralj S, Kreft ME, Krist J (2013) Targeting intracellular compartments by magnetic polymeric nanoparticles. Eur J Pharm Sci 50:130–138

    Article  Google Scholar 

  • Lee S-J, Jeong J-R, Shin S-C, Kim J-C, Chang Y-H, Chang Y-M, Kim JD (2004) Nanoparticles of magnetic ferric oxides encapsulated with poly(D, L latide-co-glycolide) and their application to magnetic resonance imaging contrast agent. J Magn Magn Mater 272–276:2432–2433

    Article  Google Scholar 

  • Li M, Neoh K-G, Wang R, Zong B-Y, Tan JY, Kang E-T (2013) Methotrexate-conjugated and hyperbranched polyglycerol-grafted Fe3O4 magnetic nanoparticles for targeted anticancer effects. Eur J Pharm Sci 48:111–120

    Article  Google Scholar 

  • Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L (2004) Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 56:185–229

    Article  Google Scholar 

  • Monneret C (2001) Recent developments in the field of antitumor anthracyclines. Eur J Med Chem 36:483–493

    Article  Google Scholar 

  • Murakami H, Kobayashi M, Takeuchi H, Kawashima Y (2000) Further application of a modified spontaneous emulsification solvent diffusion method to various types of PLGA and PLA polymers for preparation of nanoparticles. Powder Technol 107:137–143

    Article  Google Scholar 

  • Na K, Lee ES, Bae YH (2003) Adriamycin loaded pullulan acetate/sulfonamide conjugate nanoparticles responding to tumor pH: pH dependant cell interaction, internalization and cytotoxicity. J Control Release 87:3–13

    Article  Google Scholar 

  • Papadimitriou S, Bikiaris D, Avgoustakis K, Karavas E, Georgarakis M (2008) Chitosan nanoparticles loaded with dorzolamide and pramipexole. Carbohydr Polym 73:44–54

    Article  Google Scholar 

  • Ritger PL, Peppas NA (1987) A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Release 5:37–42

    Article  Google Scholar 

  • Roque ACA, Bispo S, Pinheiro ARN, Antunes JMA, Gonçalves D, Ferreira HA (2009) Antibody immobilization on magnetic particles. J Mol Recognit 22:77–82

    Article  Google Scholar 

  • Santos DP, Ruiz MA, Gallardo V, Zanoni MVB, Arias JL (2011) Multifunctional antitumor magnetite/chitosan-l-glutamic acid (core/shell) nanocomposites. J Nanopart Res 13:4311–4323

    Article  Google Scholar 

  • Seo SB, Yang J, Hyung W, Cho E-J, Lee T-I, Song YJ, Yoon H-G, Suh J-S, Huh Y-M, Haam S (2007) Novel multifunctional PHDCA/PEI nano-drug carriers for simultaneous magnetically targeted cancer therapy and diagnosis via magnetic resonance imaging. Nanotechnology 18:1–8

    Article  Google Scholar 

  • Tansik G, Yakar A, Gunduz U (2014) Tailoring magnetic PLGA nanoparticles suitable for doxorubicin delivery. J Nanopart Res 16:2171–2177

    Article  Google Scholar 

  • Wang J, Gong C, Wang Y, Wu G (2014) Magnetic nanoparticles with a pH-sheddable layer for antitumor drug delivery. Colloid Surf B 118:218–225

    Article  Google Scholar 

  • Yang J, Lee C-H, Park J, Seo S, Lim E-K, Song YJ, Suh J-S, Yoon H-G, Huh Y-M, Haam S (2007) Antibody conjugated magnetic PLGA nanoparticles for diagnosis and treatment of breast cancer. J Mater Chem 17:2695–2699

    Article  Google Scholar 

Download references

Acknowledgments

This work has been supported by Fundação para a Ciência e a Tecnologia, Portugal, through Grant No. PEst-C/EQB/LA0006/2013 and SFRH/BD/48773/2008 and contract PTDC/EQU-EPR/119631/2010. The authors would like to acknowledge Professor Ana Cecília Roque (REQUIMTE, FCT/UNL) for advice the synthesis of magnetic particles.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Margarida Cardoso.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (TIFF 142 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Peça, I.N., Bicho, A., Gardner, R. et al. Control of doxorubicin release from magnetic Poly(dl-lactide-co-glycolide) nanoparticles by application of a non-permanent magnetic field. J Nanopart Res 17, 427 (2015). https://doi.org/10.1007/s11051-015-3234-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11051-015-3234-8

Keywords

Navigation